Our website is connected to the web analytics service Yandex Metrica, which uses cookies to make your stay on our website as convenient as possible. By staying on the site, you consent to the processing of personal data in the manner set out in the Privacy Policy
Ligand Pro – is a Russian company specializing in early drug development
Year of foundation
using computational methods. We create digital tools aimed at accelerating the development of promising drug candidates. In collaboration with research groups, pharmaceutical companies, and startups, we validate the effectiveness of our approaches in real drug development pipelines.
2023
Supported by
Postgres Professional
Ligand Pro – is a Russian company specializing in early drug development using computational methods. We create digital tools aimed at accelerating the development of promising drug candidates. In collaboration with research groups, pharmaceutical companies, and startups, we validate the effectiveness of our approaches in real drug development pipelines.
What we do
Generation of Small Molecules
De novo generation of candidate molecules with optimal property profiles. Generating molecules from desired structural fragments or for a specified binding site.
Assessment of Small Molecule Interactions with Therapeutic Targets
Predicting the three-dimensional structure and binding affinity of ligand-protein complexes. Selecting high-affinity hits from compound libraries.
Optimization of Therapeutic and Diagnostic Protein Properties
Enhancing stability, improving affinity, and optimizing other parameters of proteins.
Prediction of Small Molecule Properties
Forecasting ADME-Tox profile parameters.
Our mission — efficient development of the drugs of the future using artificial intelligence.
Drug development is a lengthy process that demands significant resources. Even with the most advanced digital technologies, drug development often relies on trial and error, with no guarantee of success. We envision a future where artificial intelligence technologies can significantly reduce the time required to develop new medications.
Ligand Pro is an ambitious interdisciplinary team. We specialize in deep learning,
molecular modeling, and computational methods in chemistry and biology, applying these techniques to address various drug design challenges.
Ligand Pro is an ambitious interdisciplinary team. We specialize in deep learning, molecular modeling, and computational methods in chemistry and biology, applying these techniques to address various drug design challenges.
We collaborate with leading organizations and institutions. Together we achieve real change and success.
The Ligand Pro startup was created with the support of Postgres Professional, a Russian developer of the Postgres Pro database management system based on PostgreSQL. Postgres Professional was founded in 2015 by Oleg Bartunov and Teodor Sigaev, PostgreSQL Major Contributors, along with partners Ivan Panchenko and Andrey Fleyta.
Today, the company is one of the world’s leading vendors contributing to PostgreSQL. Postgres Professional employees are the primary developers of full-text search, JSONB, GiST, SP-GiST and GIN indexes. The team also makes contributions to B-Tree indexes and many other PostgreSQL features.
Most of the team comprises representatives from Skoltech, including students, alumni, research staff, and professors.
Skoltech is an international technological university of a new type. Combining world-class education with state-of-the-art research and applied technologies, it nurtures a new generation of technological leaders for high-tech industries. Skoltech has twice been listed among the world’s top 100 young universities according to the prestigious Nature Index ranking. The language of instruction is English.
We invite specialists in artificial intelligence, molecular modeling, medicinal chemistry,
and bio- and cheminformatics to join our team. We are also open to collaboration with pharmaceutical companies and research groups involved in development and testing of drugs.
We invite specialists in artificial intelligence, molecular modeling, medicinal chemistry, and bio- and cheminformatics to join our team. We are also open to collaboration with pharmaceutical companies and research groups involved in development and testing of drugs.
Would you like to create innovative solutions for drug design with us? Or accelerate your development pipeline using computational methods? Please reach out to us through the contact form on our website.
For all inquiries, please contact:
By clicking on the “Discuss Cooperation” button, I confirm my agreement with the provisions of the Privacy Policy
Would you like to create innovative solutions for drug design with us? Or accelerate your development pipeline using computational methods? Please reach out to us through the contact form on our website.
By clicking on the “Discuss Cooperation” button, I confirm my agreement with the provisions of the Privacy Policy
К нашему сайту подключен сервис веб-аналитики Яндекс Метрика, использующий cookie-файлы, чтобы сделать ваше пребывание на нем максимально удобным. Оставаясь на сайте, вы даете свое согласие на обработку персональных данных в порядке, указанном в Политике конфиденциальности